ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,093Medicare Part D Prescriptions Filled, Including Refills

Rank: 138 out of 336

$727K Total Retail Price of All Prescriptions

Rank: 84 out of 336

431 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 8,835 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
ATORVASTATIN CALCIUM 428 380 1 14
HYDROCODONE-ACETAMINOPHEN 312 251 S3 2 2
AMLODIPINE BESYLATE 262 250 3 1
BENAZEPRIL HCL 253 203 4 59
METOPROLOL TARTRATE 244 206 5 16
SYNTHROID 227 213 6 43
LOSARTAN POTASSIUM 220 217 7 22
SIMVASTATIN 205 193 8 5
FUROSEMIDE 195 185 9 4
LEVOTHYROXINE SODIUM 191 171 10 7
LISINOPRIL 187 179 11 6
LOVASTATIN 175 171 12 34
WARFARIN SODIUM 168 165 13 17
ATENOLOL 167 163 14 26
CRESTOR 161 145 15 25
GABAPENTIN 155 127 16 11
HYDROCHLOROTHIAZIDE 150 143 17 12
METFORMIN HCL 144 129 18 8
QUINAPRIL HCL 129 123 19 107
CLOPIDOGREL 129 118 19 28
LIPITOR 121 114 21 62
POTASSIUM CHLORIDE 113 107 22 9
SPIRONOLACTONE 112 110 23 42
NEXIUM 111 97 24 24
PRAVASTATIN SODIUM 110 101 25 10
TRAZODONE HCL 110 83 25 46
RANITIDINE HCL 110 107 25 36
METOPROLOL SUCCINATE 109 86 28 15
PREDNISONE 106 95 29 48
METFORMIN HCL ER 102 83 30 61
TRAMADOL HCL 102 74 30 20
GLIMEPIRIDE 101 80 32 29
COLCRYS 101 83 32 103
CITALOPRAM HBR 98 89 34 21
TRIAMTERENE-HCTZ 96 90 35 35
PLAVIX 92 81 36 37
RAMIPRIL 91 79 37 84
CEPHALEXIN 88 78 38 109
JANUMET 80 64 39 134
CARVEDILOL 80 60 39 13
OMEPRAZOLE 78 45 41 3
CYMBALTA 78 49 41 52
FLUTICASONE PROPIONATE 71 68 43 49
LANTUS 68 61 44 56
ALLOPURINOL 68 55 44 30
ACTOS 68 68 44 119
ADVAIR DISKUS 60 48 47 82
DIGOXIN 55 50 48 50
DIOVAN 54 54 49 31
PANTOPRAZOLE SODIUM 53 53 50 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.